Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4411 AL 4425

Spices: Potential Therapeutics for Alzheimer's Disease

Satheeshkumar N, Vijayan RS, Lingesh A, Santhikumar S, Vishnuvardhan Ch.

Adv Neurobiol. 2016;12:57-78. doi: 10.1007/978-3-319-28383-8_4.

Alzheimer's Disease and Medicinal Plants: An Overview

Manoharan S, Essa MM, Vinoth A, Kowsalya R, Manimaran A, Selvasundaram R.

Adv Neurobiol. 2016;12:95-105. doi: 10.1007/978-3-319-28383-8_6.

Potential of the Antibody Against cis-Phosphorylated Tau in the Early Diagnosis, Treatment, and Prevention of Alzheimer Disease and Brain Injury

Lu KP, Kondo A, Albayram O, Herbert MK, Liu H, Zhou XZ.

JAMA Neurol. 2016 Nov 1;73(11):1356-1362. doi: 10.1001/jamaneurol.2016.2027.

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients

Panza F, Seripa D, Solfrizzi V, Imbimbo BP, Lozupone M, Leo A, Sardone R, Gagliardi G, Lofano L, Creanza BC, Bisceglia P, Daniele A, Bellomo A, Greco A, Logroscino G.

Expert Opin Emerg Drugs. 2016 Dec;21(4):377-391. doi: 10.1080/14728214.2016.1241232. Epub 2016 Oct 6.

An Update on Biomedical Application of Nanotechnology for Alzheimer's Disease Diagnosis and Therapy

Panahi Y, Mohammadhosseini M, Abadi AJ, Akbarzadeh A, Mellatyar H.

Drug Res (Stuttg). 2016 Nov;66(11):580-586. doi: 10.1055/s-0042-112811. Epub 2016 Oct 4.

Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology

Tramutola A, Arena A, Cini C, Butterfield DA, Barone E.

Expert Rev Neurother. 2017 Jan;17(1):59-75. doi: 10.1080/14737175.2017.1246183. Epub 2016 Oct 20.

Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy

Valis M, Masopust J, Vysata O, Hort J, Dolezal R, Tomek J, Misik J, Kuca K, Karasova JZ.

Neurotox Res. 2017 Jan;31(1):162-168. doi: 10.1007/s12640-016-9672-y. Epub 2016 Oct 7.

New Age Therapy for Alzheimer's Disease by Neuronal Network Reconstruction

Tohda C.

Biol Pharm Bull. 2016;39(10):1569-1575. doi: 10.1248/bpb.b16-00438.

Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)

Knapp M, King D, Romeo R, Adams J, Baldwin A, Ballard C, Banerjee S, Barber R, Bentham P, Brown RG, Burns A, Dening T, Findlay D, Holmes C, Johnson T, Jones R, Katona C, Lindesay J, Macharouthu A, McKeith I, McShane R, O'Brien JT, Phillips PPJ, Sheehan B, Howard R.

Int J Geriatr Psychiatry. 2017 Dec;32(12):1205-1216. doi: 10.1002/gps.4583. Epub 2016 Oct 13.

Therapeutic strategies for the treatment of tauopathies: Hopes and challenges

Khanna MR, Kovalevich J, Lee VM, Trojanowski JQ, Brunden KR.

Alzheimers Dement. 2016 Oct;12(10):1051-1065. doi: 10.1016/j.jalz.2016.06.006.

Adaptive working memory strategy training in early Alzheimer's disease: randomised controlled trial

Huntley JD, Hampshire A, Bor D, Owen A, Howard RJ.

Br J Psychiatry. 2017 Jan;210(1):61-66. doi: 10.1192/bjp.bp.116.182048. Epub 2016 Oct 6.

Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy

Liu J, Yang B, Ke J, Li W, Suen WC.

Drugs Aging. 2016 Oct;33(10):685-697. doi: 10.1007/s40266-016-0406-x.

Molecular and Therapeutic Targets of Genistein in Alzheimer's Disease

Devi KP, Shanmuganathan B, Manayi A, Nabavi SF, Nabavi SM.

Mol Neurobiol. 2017 Nov;54(9):7028-7041. doi: 10.1007/s12035-016-0215-6. Epub 2016 Oct 28.

Cathepsin D as a therapeutic target in Alzheimer's disease

Di Domenico F, Tramutola A, Perluigi M.

Expert Opin Ther Targets. 2016 Dec;20(12):1393-1395. doi: 10.1080/14728222.2016.1252334. Epub 2016 Nov 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias